Wellington Management Group
MRNS

Wellington Management Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Wellington Management Group’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-294,981
Closed -$2.67M – 2000
2024
Q1 		$2.67M Buy
294,981
+53,682
+22% +$522K ﹤0.01% 1462
2023
Q4 		$2.62M Buy
241,299
+85,455
+55% +$640K ﹤0.01% 1437
2023
Q3 		$1.25M Sell
155,844
-1,134
-0.7% -$9.43K ﹤0.01% 1570
2023
Q2 		$1.7M Buy
+156,978
New +$1.34M ﹤0.01% 1507
2022
Q3 		– Sell
-87,692
Closed -$424K – 2189
2022
Q2 		$424K Hold
87,692
– – ﹤0.01% 1871
2022
Q1 		$820K Buy
87,692
+892
+1% +$8.86K ﹤0.01% 1773
2021
Q4 		$1.03M Buy
+86,800
New +$1M ﹤0.01% 1794

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group's MRNS Position: Q2 2024 in Review

Wellington Management Group sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 294,981 shares — an estimated $2.67M sold.

Wellington Management Group first reported a position in MRNS in Q4 2021 and held it in 7 quarters. The position peaked at $2.67M in Q1 2024. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Wellington Management Group reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Wellington Management Group sold 294,981 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $2.67M.
  • Wellington Management Group first reported a position in Marinus Pharmaceuticals, Inc in Q4 2021 and held it in 7 quarters.
  • Wellington Management Group's Marinus Pharmaceuticals, Inc position peaked at $2.67M in Q1 2024.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.